Muller N., M. Schwarz, “Immune System and Schizophrenia,” Current Immunology Review (2010): 213–220.

Muller, N. “Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations,” Schizophrenia Bulletin (2018): 44:973–982.

Oken, R.J., and M. Schulzer. “At Issue: Schizophrenia and Rheumatoid Arthritis: The Negative Association Revisited.” Schizophrenia Bulletin 25 (1999): 625–38.

Owen, F., and M.D. C. Simpson. “The Neurochemistry of Schizophrenia.” In S.R. Hirsch and D.R. Weinberger, eds. Schizophrenia. Oxford: Blackwell Science, 1995.

Torrey, E.F. “Are We Overestimating the Genetic Contribution to Schizophrenia?” Schizophrenia Bulletin 18 (1992): 159–70.

Torrey, E.F. “Studies of Individuals with Schizophrenia Never Treated with Antipsychotic Medications: A Review.” Schizophrenia Bulletin 58 (2002): 101–15.

Torrey, E. F, and R.H. Yolken. “Familial and Genetic Mechanisms in Schizophrenia.” Brain Research Reviews 31 (2000): 113–17.

Torrey, E. F, B.M. Barci, M.J. Webster, et al. “Neurochemical Markers for Schizophrenia, Bipolar Disorder, and Major Depression in Postmortem Brains.” Biological Psychiatry 57 (2005): 252–60.

Torrey, E. F, J.J. Bartko, and R.H. Yolken. “Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update.’’ Schizophrenia Bulletin 38 (2012): 642–47.

Torrey, E. F, J. Miller, R. Rawlings, et al. “Seasonality of Births in Schizophrenia and Bipolar Disorder: A Review of the Literature.” Schizophrenia Research 28 (1997): 1–38.

Torrey, E.F. and R.H. Yolken, “Schizophrenia and Infections: The Eyes Have It.” Schizophrenia Bulletin 43 (2017): 247–252.

Weinberger, D.R. “Schizophrenia as a Neurodevelopment Disorder.” In S.R. Hirsch and D.R. Weinberger, Schizophrenia. Oxford: Blackwell Science, 1995.

Weinberger, D.R., “Future of Days Past: Neurodevelopment and Schizophrenia.” Schizophrenia Bulletin 43 (2017): 1164–1168.

Yolken, R.H., and E.F. Torrey, “Are Some Cases of Psychosis Caused by Microbial Agents? A Review of the Evidence.” Molecular Psychiatry 13 (2008): 470–79.

Yolken, R.H., F.B. Dickerson, and E.F. Torrey. “Toxoplasma and Schizophrenia.” Parasite Immunology 31 (2009): 706–15.

Yolken, R.H., H. Karlsson, F. Yee, et al. “Endogenous Retroviruses and Schizophrenia.” Brain Research Reviews 31 (2000): 193–99.

Цитируемые источники

J. F. Duncan, “President’s Address,” Journal of Mental Science 21 (1875): 316.

Lyall Watson, quoted in J. Hooper and D. Teresi, The 3- Pound Universe (New York: MacMillan, 1986), p. 21.

M.T. Moore, D. Nathan, A.E. Elliot et al., “Encepalographic Studies in Schizophrenia,” American Journal of Psychiatry 89 (1933): 801–10.

K. Bakhshi and D.A. Chance, “The Neuropathology of Schizophrenia: A Selective Review of Past Studies and Emerging Themes in Brain Structure and Cytoarchitecture,” Neuroscience 303 (2015): 82–102.

S.V. Haijma, N.V. Haren, W. Cahn, et al., “Brain Volume in Schizophrenia: A Metaanalysis of Over 18,000 Subjects,” Schizophrenia Bulletin 29 (2013): 1129– 38.

M. A. Taylor and R. Abrams, “Cognitive Impairment in Schizophrenia,” American Journal of Psychiatry 141 (1984): 196–201.

D. W. Heinrichs and R.W. Buchanan, “Significance and Meaning of Neurological Signs of Schizophrenia,” American Journal of Psychiatry 145 (1988): 11–18.

J. A. Grebb, D.R. Weinberger, and J.M. Morihisa, “Electroencephalogram and Evoked Potentials Studies of Schizophrenia,” in H.A. Nasrallah and D.R. Weinberger, eds., The Neurology of Schizophrenia (Amsterdam: Elsevier, 1986), pp. 121–40.

E. F. Torrey, J.J. Bartko, and R.H. Yolken, “Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update,” Schizophrenia Bulletin 38 (2012): 642–47.

G. Zilboorg and G.W. Henry, A History of Medical Psychology (New York: Norton, 1941), p. 436.

“Britain’s Offbeat Psychoanalyst,” Newsweek, November 1, 1982, p. 16.

“Hubbard’s Teachings Guide Treatment of Mental Illness,” St. Petersburg Times, November 14, 1998.

S. Arzy, M. Seeck, S. Ortigue, et al., “Induction of an Illusory Shadow Person,” Nature 443 (2006): 287.

C. Farrar and C.D. Frith, “Experiencing Oneself vs Another Person as Being the Cause of an Action: The Neural Correlates of the Experience of Agency,” NeuroImage 15 (2002): 596–603.

W. A.F. Browne, What Asylums Were, Are, and Ought to Be (Edinburgh: Black, 1837), p.6.

H. Maudsley, Physiology and Pathology of the Mind (London: Macmillan, 1867), p. 367.

Huntsman, What Quarry? in Poems by Edna St. Vincent Millay (New York: Harper and Brothers, 1939).

D. R. Weinberger, “Implications of Normal Brain Development for the Pathogenesis of Schizophrenia,” Archives of General Psychiatry 44 (1987): 660–69.

E. S. Susser and S.P. Lin, “Schizophrenia after Prenatal Exposure to the Dutch Hunger Winter of 1944–1945,” Archives of General Psychiatry 49 (1992): 983–88.

E. Susser, R. Neugebauer, H.W. Hoek, et al., “Schizophrenia after Prenatal Famine,” Archives of General Psychiatry 53 (1996): 25–31.

D. St Clair, M. Xu, P. Wang, et al., “Rates of Adult Schizophrenia following Prenatal Exposure to the Chinese Famine of 1959–1961,” Journal of the American Medical Association 294 (2005): 557–62.

J. J. McGrath, T.H. Burne, F. Féron, et al., “Developmental Vitamin D Deficiency and Risk of Schizophrenia: A 10- Year Update,” Schizophrenia Bulletin 36 (2010): 1073–78.

C. C. Tennant, “Stress and Schizophrenia: A Review,” Integrative Psychiatry 3 (1985): 248–61.

E. Susser, C.S. Widom, “Still Searching for Lost Truths About the Bitter Sorrows of Childhood,” Schizophrenia Bulletin 38 (2012): 672–5.

S. Bendall, H.J. Jackson, C.A. Hulbert et al., “Childhood Trauma and Psychotic Disorders: A Systematic, Critical Review of the Evidence,” Schizophrenia Bulletin 34 (2008): 568– 79.

E. Bleuler, Dementia Praecox or the Group of Schizophrenias (New York: International Universities Press, 1950), p. 345.

Letter from Sigmund Freud to Karl Abraham in E. Jones, The Life and Work of Sigmund Freud, vol. 2 (New York: Basic Books, 1955), p. 437.

M. Shur, The Id and the Regulatory Principle of Mental Functioning (London: Hogarth, 1967), p. 21.

C. Lasch, The Culture of Narcissism (New York: Norton, 1979), p. 76.

R. C. Lewontin, S. Rose, and L.J. Kamin, Not in Our Genes (New York: Pantheon Books, 1984), p. ix.

6. Лечение шизофрении: начало

Облегчить страдания безумия всеми человеческими средствами не означает восстановить величайший из божественных даров; и те, кто посвящает себя этой задаче, не делают вид, что это так. Они находят поддержку и награду в замене жестокости на человечность, чёрствости на доброту, неистовой ярости на успокоение; вместо ненависти они несут любовь и надежду на выздоровление, а надежда есть всегда.

Чарльз Диккенс, журнал «Домашнее чтение», 1852 год

Вопреки распространённому стереотипу, шизофрения на самом деле неплохо поддаётся лечению. Но